Co-Assembly of Peptide with G-Quadruplex DNA: A Strategic Approach to Develop Anticancer Therapeutics

Biswas, S and Basak, S and Samui, S and Pasadi, S and Muniyappa, K and Naskar, J (2023) Co-Assembly of Peptide with G-Quadruplex DNA: A Strategic Approach to Develop Anticancer Therapeutics. In: ChemistrySelect, 8 (7).

PDF che_8-7_2023.pdf - Published Version Restricted to Registered users only Download (9MB) | Request a copy

Abstract

G-quadruplex (G4) is one of the non-canonical nucleic acid structures that regulate multiple key biological processes. The formation of G4 hinders the progression of cancer. The molecular entities which can stabilize the G4 structure are very important to design anticancer therapeutics. Herein, it is described that a synthetic dendron-like peptide, Cδ3-(YYEE)-E co-assembles with G4 DNA in aqueous buffer containing Na+ ions. Various orthogonal biophysical studies have established the co-assembly phenomenon. In silico, molecular docking studies also corroborate the results obtained from biophysical experiments. Importantly, the co-assembly enhances the thermal stability of G4 DNA compared to free G4 DNA. The peptide inhibits the activity of telomerase enzyme which is found to be over-expressed in most of the cancer cells and also down-regulates the c-Myc oncogenic expression. The peptide exhibits significant cytotoxic effect on cancer cells (HeLa and U2OS) compared to non-cancer cells (HEK293) under similar experimental conditions. The study highlights the applicability of a synthetic bioactive peptide as a putative anticancer therapeutic. © 2023 Wiley-VCH GmbH.

Item Type:	Journal Article
Publication:	ChemistrySelect
Publisher:	John Wiley and Sons Inc
Additional Information:	The copyright of this article belongs to John Wiley and Sons Inc.
Keywords:	Apoptosis; Oncogene; Peptide; Quadruplex DNA; Telomerase
Department/Centre:	Division of Biological Sciences > Biochemistry
Date Deposited:	10 Mar 2023 10:31
Last Modified:	10 Mar 2023 10:31
URI:	https://eprints.iisc.ac.in/id/eprint/80951

Actions (login required)

View Item